Evolent (EVH)
Runs risk-based and fee-based specialty-care programs covering oncology, cardiology, and musculoskeletal conditions for health plans.
$3.78
After-hours close−0.01 (−0.26%)
At close$3.79(+2.71%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 101.22% | 114.44M shares | |
|---|---|---|---|
| 207 holders · as of Jun 30, 2026 | |||
| Insiders | 2.60% | 2.94M shares | |
| 17 holders · as of Aug 28, 2026 | |||
| Strategic holders | 5.21% | 5.89M shares | |
| 1 holder · as of Feb 3, 2022 | |||
| Adds to | 109.03% | ||
113.06M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 109.03%; nothing is left for Other.
13F, as of Jun 30, 2026
207 holders · 114.44M shares · 39 new positions · 107 increased · 65 reduced · 30 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.81M | 13.10% | +3.93M | Aug 7, 2026 |
| Cadian Capital Management, LP | 10.81M | 9.57% | 0 | Aug 14, 2026 |
| Morgan Stanley | 8.97M | 7.93% | −112.1K | Aug 13, 2026 |
| UBS Group AG | 6.25M | 5.52% | −1.91M | Aug 13, 2026 |
| Rubicon Founders LLC | 5.82M | 5.14% | 0 | Aug 14, 2026 |
| Engaged Capital LLC | 5.56M | 4.92% | 0 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | 5.11M | 4.52% | −326.5K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.79M | 4.23% | −79.4K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Cadian Capital Management, LP | 9.30% | 10.79M | 13G | May 15, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Daniel Joseph McCarthyofficer: PRESIDENT | Sale | 65,892 | $5.00 | 655,133 |
| Nov 18, 2025 | Brendan B. Springstubbdirector | Purchase | 10,000 | $3.82 | 58,821 |
House and Senate disclosures
Not reported.